Intracellular Ca2+ remodeling during the phenotypic journey of human coronary smooth muscle cells

Cell Calcium

Volumn 54, Issue 5, 2013, Pages 375-385

  Muñoz, Eva ^a   Hernández Morales, Miriam ^a   Sobradillo, Diego ^a   Rocher, Asunción ^b   Núñez, Lucía ^b   Villalobos, Carlos ^a  

^a University of Valladolid   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Mitochondria; Non steroidal anti inflammatory drugs; Store operated calcium entry; Store operated current; Vascular smooth muscle cells; Voltage operated calcium entry

Indexed keywords

ANGIOTENSIN II; CALCIUM CHANNEL; CALCIUM CHANNEL CAV1.2; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1; MESSENGER RNA; STROMAL INTERACTION MOLECULE 1; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM METABOLISM; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELL KINETICS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MITOCHONDRION; MUSCLE CELL; ORAI1 GENE; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR SMOOTH MUSCLE CELL;

MITOCHONDRIA; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; STORE-OPERATED CALCIUM ENTRY; STORE-OPERATED CURRENT; VASCULAR SMOOTH MUSCLE CELLS; VOLTAGE-OPERATED CALCIUM ENTRY;

ANGIOTENSIN II; ANTI-INFLAMMATORY AGENTS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; IONS; LUMINESCENT MEASUREMENTS; MEMBRANE PROTEINS; MITOCHONDRIA; MYOCYTES, SMOOTH MUSCLE; NEOPLASM PROTEINS; PATCH-CLAMP TECHNIQUES; PHENOTYPE;

EID: 84885481186     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2013.08.006     Document Type: Article

References (38)

1. Campbell G.R., Campbell J.H. Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. Exp. Mol. Pathol. 1985, 42:139-162.
2. de la Torre-Hernández J.M., Alfonso F., Gimeno F., Diarte J.A., Lopez-Palop R., Pérez de Prado A., Rivero F., Sanchis J., Larman M., Díaz J.F., Elizaga J., Moreiras J.M., Gómez-Jaume A., Hernández J.M., Mauri J., Recalde A.S., Bullones J.A., Rumoroso J.R., del Blanco B.G., Baz J.A., Bosa F., Botas J., Hernández F. Thrombosis of second-generation drug-eluting stents in real practice. JACC Cardiovasc. Interv. 2010, 3:911-919.
3. Stefanini G.G., Holmes D.R. Drug-eluting coronary-artery stents. N. Engl. J. Med. 2013, 368:254-265.
4. Beech D.J. Ion channel switching and activation in smooth-muscle cells of occlusive vascular diseases. Biochem. Soc. Trans. 2007, 35:890-894.
5. House S.J., Potier M., Bisaillon J., Singer H.A., Trebak M. The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease. Pflugers Arch. 2008, 456:769-785.
6. 2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am. J. Physiol. Cell Physiol. 2008, 295:C779-C790.
7. Miguel-Velado E., Pérez-Carretero F.D., Colinas O., Cidad P., Heras M., López-López J.R., Pérez-García M.T. Cell cycle-dependent expression of Kv3.4 channels modulates proliferation of human uterine artery smooth muscle cells. Cardiovasc. Res. 2010, 86:383-391.
8. Parekh A.B., Putney J.W. Store-operated calcium channels. Physiol. Rev. 2005, 85:757-810.
9. Takahashi Y., Watanabe H., Murakami M., Ono K., Munehisa Y., Koyama T., Nobori K., Iijima T., Ito H. Functional role of stromal interaction molecule 1 (STIM1) in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 2007, 361:934-940.
10. Peel S.E., Liu B., Hall I.P. Orai and store-operated calcium influx in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 2008, 38:744-749.
11. Guo R.W., Yang L.X., Li M.Q., Pan X.H., Liu B., Deng Y.L. Stim1- and Orai1-mediated store-operated calcium entry is critical for angiotensin II-induced vascular smooth muscle cell proliferation. Cardiovasc. Res. 2012, 93:360-370.
12. Powell J.S., Müller R.K., Rouge M., Kuhn H., Hefti F., Baumgartner H.R. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J. Cardiovasc. Pharmacol. 1990, 16:42-49.
13. 2+ influx. Curr. Biol. 2005, 15:1235-1241.
14. Feske S., Gwack Y., Prakriya M., Srikanth S., Puppel S.H., Tanasa B., Hogan P.G., Lewis R.S., Daly M., Rao A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 2006, 441:179-185.
15. Hogan P.G., Lewis R.S., Rao A. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu. Rev. Immunol. 2010, 28:491-533.
16. Aubart F.C., Sassi Y., Coulombe A., Mougenot N., Vrignaud C., Leprince P., Lechat P., Lompré A.M., Hulot J.S. RNA interference targeting STIM1 suppresses vascular smooth muscle cell proliferation and neointima formation in the rat. Mol. Ther. 2009, 17:455-462.
17. Guo R.W., Wang H., Gao P., Li M.Q., Zeng C.Y., Yu Y., Chen J.F., Song M.B., Shi Y.K., Huang L. An essential role for stromal interaction molecule 1 in neointima formation following arterial injury. Cardiovasc. Res. 2009, 81:660-668.
18. 2+ entry in mouse pulmonary arterial smooth muscle cells. J. Physiol. (Lond.) 2009, 587:2429-2442.
19. Zhang W., Halligan K.E., Zhang X., Bisaillon J.M., Gonzalez-Cobos J.C., Motiani R.K., Hu G., Vincent P.A., Zhou J., Barroso M., Singer H.A., Matrougui K., Trebak M. Orai1-mediated Icrac is essential for neointima formation after vascular injury. Circ. Res. 2011, 19:534-542.
20. Corriu C., André P., Schott C., Michel M., Stoclet J.C. AngII receptor expression and function during phenotypic modulation of rat aortic smooth muscle cells. Am. J. Physiol. 1994, 266:H631-H636.
21. CÔrtes S.F., Lemos V.S., Stoclet J.C. Alterations in calcium stores in aortic myocytes from spontaneously hypertensive rats. Hypertension 1997, 29:1322-1328.
22. Reis E.D., Roque M., Dansky H., Fallon J.T., Badimon J.J., Cordon-Cardo C., Shiff S.J., Fisher E.A. Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:12764-12769.
23. Weber A., Yildirim H., Schrör K. Cyclooxygenase-independent inhibition of smooth muscle cell mitogenesis by ibuprofen. Eur. J. Pharmacol. 2000, 389:67-69.
24. Brooks G., Yu X.M., Wang Y., Crabbe M.J., Shattock M.J., Harper J.V. Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit vascular smooth muscle cell proliferation via differential effects on the cell cycle. J. Pharm. Pharmacol. 2003, 55:519-526.
25. 2+-dependent inactivation of calcium release-activated calcium/orai channels normally prevented by mitochondria. J. Biol. Chem. 2011, 286:16186-16196.
26. Villalobos C., Alonso M.T., García-Sancho J. Bioluminescence imaging of calcium oscillations inside intracellular organelles. Methods Mol. Biol. 2009, 574:203-214.
27. 2+ uptake: inhibition by salicylate. J. Physiol. 2006, 571:57-73.
28. Villalobos C., Caballero E., Sanz-Blasco S., Núñez L. Study of neurotoxic intracellular calcium signaling triggered by amyloids. Methods Mol. Biol. 2012, 849:289-302.
29. 2+ signal, transcription factor NFAT and proliferation in human vascular smooth muscle cells. J. Mol. Cell. Cardiol. 2011, 50:621-633.
30. 3 pituitary cells. Pflügers Arch. 1995, 430:923-935.
31. 2+homeostasis: mechanism, role, and tissue specificities. Pflugers Arch. 2012, 464:3-17.
32. 2+ release in arterial smooth muscle. Circ. Res. 2010, 106:1285-1289.
33. Chalmers S., Saunter C., Wilson C., Coats P., Girkin J.M., McCarron J.G. Mitochondrial motility and vascular smooth muscle proliferation. Arterioscler. Thromb. Vasc. Biol. 2012, 32:3000-3011.
34. Park C.Y., Shcheglovitov A., Dolmetsch R. The CRAC channel activator STIM1 binds and inhibits L-type voltage-gated calcium channels. Science 2010, 330:101-105.
35. 2+ channels. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:4040-4045.
36. Hoth M., Fanger C.M., Lewis R.S. Mitochondrial regulation of store-operated calcium signalling in T lymphocytes. J. Cell Biol. 1997, 137:633-648.
37. 2+ uptake. EMBO J. 2002, 21:6744-6754.
38. Hoth M., Button D.C., Lewis R.S. Mitochondrial control of calcium-channel gating: a mechanism for sustained signaling and transcriptional activation in T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:10607-10611.